Vir Biotechnology, Inc. (VIR)
9.06
+0.04
(+0.44%)
USD |
NASDAQ |
Apr 02, 16:00
9.045
-0.02
(-0.17%)
After-Hours: 20:00
Vir Biotechnology Research and Development Expense (TTM) : 432.80M for Dec. 31, 2025
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Hims & Hers Health, Inc. | 149.30M |
| BioMarin Pharmaceutical, Inc. | 700.97M |
| Xeris Biopharma Holdings, Inc. | 31.16M |
| Gossamer Bio, Inc. | 174.07M |
| Sensei Biotherapeutics, Inc. | 15.38M |